Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing parallel trial of DIMS lenses plus low-dose atropine for pediatric myopia control
2021-003373-64Phase 4Active
- Sponsor
- NOEMI GUEMES VILLAHOZ
- Start
- Jul 2021
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of atropine in myopia, sponsored by NOEMI GUEMES VILLAHOZ. Primary endpoint: Refractive error after cycloplegia. Started Jul 2021; status: active.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on 2021-003373-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003373-64.